Literature DB >> 17472700

Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells.

Elli Kyratzi1, Maria Pavlaki, Dimitra Kontostavlaki, Hardy J Rideout, Leonidas Stefanis.   

Abstract

Mutations in Parkin, an E3 ligase, which participates in the ubiquitin-proteasome system (UPS), cause juvenile onset Parkinson's disease (PD). Some mutants aggregate upon over-expression, but the effects of such aggregation on the UPS and neuronal survival have not been characterized. We show in this study that transient over-expression of wild type (WT) Parkin or various mutants in human neuroblastoma cells leads to localized accumulation of green fluorescent protein (GFP(u)), an artificial proteasomal substrate, indicative of UPS dysfunction. Parkin mutants, but not WT, aggregated, and GFP(u) and ubiquitin accumulated within such aggregates. Apoptotic death occurred only with mutant Parkin over-expression, and correlated with aggregation, but not GFP(u) accumulation. Enzymatic proteasomal activity was slightly increased with WT Parkin and decreased with mutant Parkin over-expression. This decrease was, at least in part, due to caspase activation. We conclude that mutant forms of Parkin can exert toxic effects on neuronal cells, possibly through their propensity to aggregate. Both WT and mutant forms can induce localized UPS dysfunction, likely through different mechanisms. This raises a note of caution regarding forced over-expression of Parkin as a neuroprotective strategy in PD or other neurodegenerative conditions and suggests a possible toxic gain of function for certain mutant forms of Parkin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472700     DOI: 10.1111/j.1471-4159.2007.04620.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Authors:  Dan Hu; Jian-Yi Niu; Jing Xiong; Shu-Ke Nie; Fei Zeng; Zhao-Hui Zhang
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination.

Authors:  M Rafiuddin Ahmed; Xuanzhi Zhan; Xiufeng Song; Seunghyi Kook; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Biochemistry       Date:  2011-04-12       Impact factor: 3.162

3.  Protective effects of zonisamide against rotenone-induced neurotoxicity.

Authors:  Salvatore Condello; Monica Currò; Nadia Ferlazzo; Gregorio Costa; Giuseppa Visalli; Daniela Caccamo; Laura Rosa Pisani; Cinzia Costa; Paolo Calabresi; Riccardo Ientile; Francesco Pisani
Journal:  Neurochem Res       Date:  2013-10-20       Impact factor: 3.996

4.  Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.

Authors:  Shan Guan; Yanling Zhao; Jiaxiong Lu; Yang Yu; Wenjing Sun; Xinfang Mao; Zhenghu Chen; Xin Xu; Jessie Pan; Surong Sun; Jianhua Yang
Journal:  Oncotarget       Date:  2016-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.